Dianthus Therapeutics
- Market cap
- 4.75B
- P/E (TTM)i
- -20.02
- P/Bi
- 4.05
- EPSi
- -4.20
- Div yieldi
- 0.00%
- 52W posi
- 61%
Anonymous reader poll. Unscientific, not investment advice.
Dianthus Therapeutics last traded at 84.88, down 0.61% on the session. That leaves the company valued at approximately 4.75B, the #2155 most valuable US-listed company we track. The 13 analysts covering the stock are, on balance, at Buy, targeting an average of 142.82 (+68%). The shares sit 61% of the way up their 52-week range of 32.22 to 117.88.
✦ StockVane Quant Insights how this is computed
- Twelve-month momentum in the top 3% of the universe, above its 200-day average.
- Signal has read BUY for 6 months.
- Its last 3 Buy calls have averaged +18% over the following quarter.
- Recent price momentum is +66.6% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 15.8% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 85.40
- Open
- 84.60
- Day range
- 84.13 - 86.61
- Avg price
- 85.24
- Volume
- 562.47K
- Turnover
- 47.95M
- Turnover ratei
- 1.01%
- Volume ratioi
- 0.63
- Amplitudei
- 2.90%
- 52-week rangei
- 32.22 - 117.88
Valuation
- P/Ei
- -20.21
- P/E (TTM)i
- -20.02
- P/Bi
- 4.05
- EPSi
- -4.20
- Book value / shi
- 20.95
- Net profit
- -234.92M
- Net assets
- 1.17B
Share structure
- Market cap
- 4.75B
- Float capi
- 4.74B
- Shares out
- 55.93M
- Float sharesi
- 55.81M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
28.0% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-6.62M net over the window
Short interest
- Shares short
- 8.83M
- % of floati
- 15.79%
- Days to coveri
- 14.42
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Dianthus Therapeutics (DNTH)?
Dianthus Therapeutics last traded at 84.88. The quote on this page refreshes every few seconds while US markets are open.
What is Dianthus Therapeutics's market cap?
About 4.75B.
What is the P/E ratio of Dianthus Therapeutics?
The trailing twelve-month P/E is -20.02. The Valuation tab shows it against the stock's own five-year range.
Does Dianthus Therapeutics pay a dividend?
Dianthus Therapeutics does not currently pay a regular dividend.
Is Dianthus Therapeutics a buy according to analysts?
The consensus of 13 analysts is a Buy rating, with an average 12-month price target of 142.82, which implies 68.3% upside from the current price. This is not investment advice.
What is Dianthus Therapeutics's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Dianthus Therapeutics a B (Buy). Twelve-month momentum in the top 3% of the universe, above its 200-day average. Not investment advice.
Quote time 2026-10-07 21:26:06 · For reference only, not investment advice and not tailored to your situation.